![]() |
Name |
Thiosulfuric acid
|
Molecular Formula | H2O3S2 | |
IUPAC Name* |
sulfurothioic O-acid
|
|
SMILES |
OS(=O)(=S)O
|
|
InChI |
InChI=1S/H2O3S2/c1-5(2,3)4/h(H2,1,2,3,4)
|
|
InChIKey |
DHCDFWKWKRSZHF-UHFFFAOYSA-N
|
|
Synonyms |
Thiosulfuric acid; sulfurothioic S-acid; 13686-28-7; Monosulfanemonosulfonic acid; 7K79Y2EKKP; Thiosulfuric acid (H2S2O3); H2S2O3; CHEBI:29279; sulfurothioic O-acid; UNII-7K79Y2EKKP; dihydroxidooxidosulfidosulfur; mercaptosulfonic acid; hydroxidodioxidosulfanidosulfur; [SO(OH)2S]; CHEBI:5587; [SO2(OH)(SH)]; CHEMBL1208642; DTXSID00159981; ZINC8214573; DB09499; C05529; Q420074
|
|
CAS | 13686-28-7 | |
PubChem CID | 24478 | |
ChEMBL ID | CHEMBL1208642 |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 114.15 | ALogp: | 0.3 |
HBD: | 2 | HBA: | 4 |
Rotatable Bonds: | 0 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 98.0 | Aromatic Rings: | 0 |
Heavy Atoms: | 5 | QED Weighted: | 0.469 |
Caco-2 Permeability: | NA | MDCK Permeability: | NA |
Pgp-inhibitor: | NA | Pgp-substrate: | NA |
Human Intestinal Absorption (HIA): | NA | 20% Bioavailability (F20%): | NA |
30% Bioavailability (F30%): | NA |
Blood-Brain-Barrier Penetration (BBB): | NA | Plasma Protein Binding (PPB): | NA |
Volume Distribution (VD): | NA | Fu: | NA |
CYP1A2-inhibitor: | NA | CYP1A2-substrate: | NA |
CYP2C19-inhibitor: | NA | CYP2C19-substrate: | NA |
CYP2C9-inhibitor: | NA | CYP2C9-substrate: | NA |
CYP2D6-inhibitor: | NA | CYP2D6-substrate: | NA |
CYP3A4-inhibitor: | NA | CYP3A4-substrate: | NA |
Clearance (CL): | NA | Half-life (T1/2): | NA |
hERG Blockers: | NA | Human Hepatotoxicity (H-HT): | NA |
Drug-inuced Liver Injury (DILI): | NA | AMES Toxicity: | NA |
Rat Oral Acute Toxicity: | NA | Maximum Recommended Daily Dose: | NA |
Skin Sensitization: | NA | Carcinogencity: | NA |
Eye Corrosion: | NA | Eye Irritation: | NA |
Respiratory Toxicity: | NA |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC000132 | ![]() |
0.176 | D08OKJ | ![]() |
0.500 | ||
ENC000465 | ![]() |
0.176 | D0P9NT | ![]() |
0.294 | ||
ENC000522 | ![]() |
0.150 | D06UNR | ![]() |
0.185 | ||
ENC000037 | ![]() |
0.150 | D0BG4W | ![]() |
0.167 | ||
ENC000019 | ![]() |
0.143 | D07CEI | ![]() |
0.167 | ||
ENC000677 | ![]() |
0.136 | D02LDN | ![]() |
0.167 | ||
ENC000009 | ![]() |
0.125 | D01BQK | ![]() |
0.167 | ||
ENC000031 | ![]() |
0.125 | D0VB3Y | ![]() |
0.167 | ||
ENC000824 | ![]() |
0.115 | D0T5DE | ![]() |
0.167 | ||
ENC001095 | ![]() |
0.111 | D03IDU | ![]() |
0.154 |